InvestorsHub Logo

slunj

09/05/19 4:27 PM

#1799 RE: DollarSquad #1798

The updated direction of halting the calorie counter and focusing on the blood glucose monitor as a higher margin business was already announced and the recent security offering expects a working GCM clinical watch to be completed this 4Q as well as an FDA pre submission meeting during the same quarter.